Home / Share Price Target / Godavari
Godavari Drugs Share Price Target 2024, 2025, 2026 to 2039 With Charts
Godavari Drugs Limited | |||
 | Symbol: GODAVARI | ||
| Price: ₹128.3 | |||
| Exchange: BSE | |||
| -> | |||
Show Table of Contents
Table of Contents
- 0.1: Godavari Drugs Financial Performance
- 0.1.1: Is Godavari Drugs A Good Buy For Long Term?
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Godavari Drugs Share Price Target For 2024
- 1.1.1: Godavari Drugs Share Price Target Table For 2024
- 1.1.2: Summary: Godavari Drugs Share Price Prediction For 2024
- 1.2: Godavari Drugs Share Price Target For 2025
- 1.2.1: Godavari Drugs Share Price Target Table For 2025
- 1.2.2: Summary: Godavari Drugs Share Price Prediction For 2025
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Godavari Drugs Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 2.2: Godavari Drugs Share Price Target Table From 2024, 2025, 2026 to 2039
- 3: Godavari Drugs Past Performance
Advertisement
Godavari Drugs Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 93.37 Crore | Market valuation of Godavari Drugs's shares. |
| Revenue (TTM) | 156.71 Crore | Total revenue generated by Godavari Drugs over the past twelve months. |
| Net Income (TTM) | +5.54 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 6.83% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 22.9% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | -16.65% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | -9.07% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 1.48 | Company's total debt divided by total shareholder equity. |
| Total Debt | 57.77 Crore | Sum of Godavari Drugs's current & long-term financial obligations. |
| Total Cash | 11.88 Lakh | Total amount of liquid funds available to Godavari Drugs. |
Is Godavari Drugs A Good Buy For Long Term?
Godavari Drugs is a small-cap company with a strong track record of growth, reflected in its impressive 5-year return of 427.44%. However, the recent decline in revenue (-16.65% QoQ) and profit (-9.07% YoY) raises concerns. Additionally, the company has a significant debt burden of 57.77 Crore against a meager cash balance of 11.88 Lakh. While the high profit margin of 22.9% is encouraging, the debt burden and recent performance dips require close monitoring. Overall, it's too early to definitively call Godavari Drugs a "good buy" for the long term. Investors should closely watch future quarters to assess the company's ability to manage its debt and regain growth momentum.
To predict the Godavari Drugs's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Godavari Drugs Share Price Target For 2024
The line chart displays the monthly closing prices of Godavari Drugs with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Godavari Drugs shares in 2024, see the table below.
Advertisement
Godavari Drugs Share Price Target Table For 2024
| Godavari Drugs's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 135.00 (+5.22%) | Price Action: 13 Sep 2024 Low |
| 2024 Target 2 | 133.00 (+3.66%) | Price Action: Aug 2024 Low |
| 2024 Target 1 | 131.50 (+2.49%) | Price Action: 12 Sep 2024 Low |
| Current Price | 128.30 | Godavari Drugs's 1 share price as of Thu 17 Oct 2024 |
| Stop Loss 1 | 126.85 (-1.14%) | Price Action: 09 Oct 2024 High |
| Stop Loss 2 | 125.00 (-2.58%) | Price Action: 20 Sep 2024 Low |
| Stop Loss 3 | 123.15 (-4.02%) | Price Action: 10 Oct 2024 Low |
Summary: Godavari Drugs Share Price Prediction For 2024
In summary, Godavari Drugs has surged by ₹38.24, achieving a notable +42.46% increase from 1st January 2024 to 17 Oct 2024. Our analysis of Godavari Drugs for 2024 predicts an additional rise of 2.49% to 5.22% by the end of 2024 with three potential targets T1: 131.50, T2: 133.00, T3: 135.00. Stop Loss at SL1: 126.85, SL2: 125.00, SL3: 123.15.
Godavari Drugs has a 52-week high of ₹155.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹82.10, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Godavari Drugs.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Godavari Drugs Share Price Target For 2025
The line chart displays the monthly closing prices of Godavari Drugs with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Godavari Drugs shares in 2025, see the table below.
Advertisement
Godavari Drugs Share Price Target Table For 2025
| Godavari Drugs's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 178.95 (+39.47%) | Price Action: Chart |
| 2025 Target 2 | 175.61 (+36.87%) | Custom Fibonacci Extension Lvl 64.9% |
| 2025 Target 1 | 172.20 (+34.21%) | Fibonacci Extension Level 123.6% |
| Current Price | 128.30 | Godavari Drugs's 1 share price as of Thu 17 Oct 2024 |
| Stop Loss 1 | 115.60 (-9.9%) | Price Action: 07 Oct 2024 Low |
| Stop Loss 2 | 114.00 (-11.15%) | Price Action: Sep 2023 High |
| Stop Loss 3 | 112.42 (-12.38%) | Technical Indicator: MA100 |
Summary: Godavari Drugs Share Price Prediction For 2025
In summary, Godavari Drugs has surged by ₹38.24, achieving a notable +42.46% increase from 1st January 2024 to 17 Oct 2024. Our analysis of Godavari Drugs for 2025 predicts an additional rise of 34.21% to 39.47% by the end of 2025 with three potential targets T1: 172.20, T2: 175.61, T3: 178.95. Stop Loss at SL1: 115.60, SL2: 114.00, SL3: 112.42.
Godavari Drugs has a All-Time high of ₹155.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹82.10, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Godavari Drugs, we have created a specific page for that check here: Godavari Drugs Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Godavari Drugs Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Godavari Drugs share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 13.3% over the next 15 years.
For complete year by year Godavari Drugs long term share price target from 2024, 2025 to 2039 check the below table.
Godavari Drugs Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Godavari Drugs Target | YoY Change % |
|---|---|---|
| 2024 | ₹128.3 | [Current Price] |
| 2024 | ₹140.1 | 9.19% |
| 2025 | ₹183.89 | 31.25% |
| 2026 | ₹228.32 | 24.16% |
| 2027 | ₹279.14 | 22.26% |
| 2028 | ₹340.86 | 22.1% |
| 2029 | ₹382.55 | 12.23% |
| 2030 | ₹420.31 | 9.87% |
| 2031 | ₹461.82 | 9.87% |
| 2032 | ₹516.15 | 11.76% |
| 2033 | ₹588.24 | 13.96% |
| 2034 | ₹625.01 | 6.25% |
| 2035 | ₹656.72 | 5.07% |
| 2036 | ₹695.32 | 5.87% |
| 2037 | ₹753.15 | 8.31% |
| 2038 | ₹835.63 | 10.95% |
| 2039 | ₹804.84 | -3.69% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Godavari Drugs Past Performance
- In 2002, Godavari Drugs opening price was ₹1.75
- As of Thu 17 Oct 2024 the price stands at ₹128.3.
- This represents a Compound Annual Growth Rate (CAGR) of 20.53%.
- In 22 years, an investment of 10,000 would have become ₹7.33 Lakh.
As we wrap up, we hope you like our study on Godavari Drugs share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
